Literature DB >> 7054860

The molecular nature of vascularly released cholecystokinin from the isolated perfused porcine duodenum.

J F Rehfeld, J J Holst, S L Jensen.   

Abstract

Using sequence-specific radioimmunoassays, the quantities and molecular nature of cholecystokinin (CCK) have been determined in extracts of porcine duodenal mucosa and in the vascular perfusate from the isolated porcine duodenum. The basal concentration of CCK in the perfusate was 84 pM equiv. CCK-8 (mean; range: 32-173 pM, n = 5). After intraluminal stimulation with amino acids, acidified fat emulsions and hydrochloric acid, the concentrations increased 2--5-fold. Both in the basal and stimulated state the concentrations of the related hormone, gastrin, were below 5 pM equiv. gastrin-17. CCK in the perfusate was concentrated by affinity-chromatography using antibodies directed against the bioactive C-terminus. Subsequent gel chromatography revealed a form with a size like or slightly larger than the C-terminal dodecapeptide (CCK-12), a predominant form resembling the C-terminal octapeptide (CCK-8), and a form resembling the C terminal tetrapeptide (CCK-4). The duodenal mucosa contained in addition CCK-33, -39 and CCK-peptides with further N-terminal extensions. The results suggest that small CCK peptides are the principal circulating forms, while CCK-33 and larger forms are biosynthetic precursors.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7054860     DOI: 10.1016/0167-0115(82)90003-9

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  5 in total

1.  Plasma concentrations of cholecystokinin, CCK-8, and CCK-33, 39 in rats, determined by a method based on enzyme digestion of gastrin before HPLC and RIA detection of CCK.

Authors:  A Lindén; M Carlquist; S Hansen; K Uvnäs-Moberg
Journal:  Gut       Date:  1989-02       Impact factor: 23.059

2.  Inactivation of cholecystokinin octapeptide by normal and cirrhotic liver in rats.

Authors:  Z Berger; A Pap; I Ungi; V Varró
Journal:  Int J Pancreatol       Date:  1986-10

3.  Comparison of hepatic elimination of different forms of cholecystokinin in dogs. Bioassay and radioimmunoassay comparisons of cholecystokinin-8-sulfate and -33-sulfate.

Authors:  T Sakamoto; M Fujimura; J Newman; X G Zhu; G H Greeley; J C Thompson
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

Review 4.  Cholecystokinin-From Local Gut Hormone to Ubiquitous Messenger.

Authors:  Jens F Rehfeld
Journal:  Front Endocrinol (Lausanne)       Date:  2017-04-13       Impact factor: 5.555

5.  Establishment of a model for equine small intestinal disease: effects of extracorporeal blood perfusion of equine ileum on metabolic variables and histological morphology - an experimental ex vivo study.

Authors:  Maria S Unterköfler; Bruce C McGorum; Elspeth M Milne; Theresia F Licka
Journal:  BMC Vet Res       Date:  2019-11-08       Impact factor: 2.741

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.